Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek;Traitement palliatif par imiquimod d'un mélanome de Dubreuilh étendu de la joue

Annales de Dermatologie et de Venereologie

Volumn 137, Issue 2, 2010, Pages 142-144

  Cheikhrouhou, H ^a   Pouaha, J ^a   Claeys, A ^a   Truchetet, F ^a  

^a Centre Hospitalier Regional Metz Thionville   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

CHEEK; HUMAN; LETTER; MALIGNANT LENTIGO; PALLIATIVE THERAPY;

ADMINISTRATION, TOPICAL; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CHEEK; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; PALLIATIVE CARE; SKIN NEOPLASMS;

EID: 76549120429     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2010.01.002     Document Type: Letter

References (7)

1. Buettiker U.V., Yawalkar N.Y., Braathen L.R., and Hunger R.E. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients. Arch Dermatol 144 (2008) 943-945
2. Ahmed I., and Berth-jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol 143 (2000) 843-845
3. Ramsdell A.M., and Zeitouni N. Long term follow up of a hemifacial lentigo maligna treated using 5% imiquimod. Dermatol Surg 35 (2009) 287-290
4. Rajpar S.F., and Marsden J.R. Imiquimod in the treatment of lentigo maligna. Br J Dermatol 155 (2006) 653-656
5. Wolf I.H., Cerroni L., Kodama K., and Kerl H. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod. Arch Dermatol 141 (2005) 510-514
6. Powell A.M., Robson A.M., Russel-Jones R., and Barlow R.J. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. Br J Dermatol 160 (2009) 994-998
7. Temple C.L., and Arlette J.P. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J Surg Oncol 94 (2006) 287-292